Beckman Coulter Announces FDA Clearance Of UniCel(R) DxH 800
Beckman Coulter, Inc. ushers in a new era of cellular analysis with the release of the UniCel(R) DxH 800 Coulter(R) Cellular Analysis System. Capturing 29 individual measurements per cell analyzed, the system provides improved sensitivity and specificity, which means more reliable assessment of abnormal cell populations. Laboratories equipped with the system will be able to respond more quickly and accurately to physician demands, improving patient health and reducing the cost of care. The system’s all new physical design minimizes moving parts, increasing instrument reliability and technologist efficiency.
- Merit Medical gets FDA approval on torque device
- Sorin Group Announces The Japanese Approval And Market Release Of Defibrillation Lead: Isoline™
- Intel Announces its First Home Medical Device to Better Connect Clinicians With Patients
- FDA clears new test to detect kidney disease
